Biogen shares fall after Alzheimer’s drug approval. Here’s what the pros are saying
Pros on CNBC discussed Biogen after the Food and Drug Administration approved its Alzheimer's drug.
Source link
- Pulsar Fusion wants to use nuclear fusion to make interstellar space travel a reality
- Investigation launched following alleged death threats to French officer who killed teen
